Anthera Pharmaceuticals (ANTH) Short Interest Ratio & Short Volume

Short interest is the volume of Anthera Pharmaceuticals shares that have been sold short but have not yet been covered or closed out. As of October 31st, investors have sold 3,400 shares of ANTH short. Learn More on Anthera Pharmaceuticals' current short interest.

Here is how the short interest of companies in the industry of "pharmaceutical products" compare to Anthera Pharmaceuticals: Alvotech (0.07%),

As of the most recent reporting period, the following stocks had the largest short interest positions: Charter Communications, Inc. ($4.08 billion), AppLovin Co. ($3.18 billion), Paychex, Inc. ($2.64 billion), Nu Holdings Ltd. ($2.54 billion), International Paper ($2.46 billion), Cencora, Inc. ($2.27 billion), Moderna, Inc. ($1.87 billion), SoFi Technologies, Inc. ($1.81 billion), Lululemon Athletica Inc. ($1.75 billion), and Onsemi ($1.71 billion). View all of the most shorted stocks.

Short selling ANTH is an investing strategy that aims to generate trading profit from Anthera Pharmaceuticals as its price is falling. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

A short squeeze for Anthera Pharmaceuticals occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of ANTH, which in turn drives the price of the stock up even further.

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including ANTH, twice per month. The most recent reporting period available is October, 31 2024.